Okyo Pharma Ltd - London-headquartered biotechnology company - Says patent entitled 'compounds & methods for treating pain' was issued by the US Patent & Trademark Office on January 26. This patent covers a class of bovine adrenal medulla peptides linked to specific lipids that demonstrate potential for treating symptoms of neuropathic pain, ocular pain, ocular inflammation and/or dry eye disease.
"The publication of this patent on our bovine adrenal medulla-lipidated analogues provides key intelectual property protection crucial for bringing forward a candidate from this class into the clinic," said Chief Executive Gary Jacob.
Current stock price: 9.43 pence
Year-to-date change: up 26%
By Evelina Grecenko; email@example.com
Copyright 2021 Alliance News Limited. All Rights Reserved.